The landscape of cellular immunotherapy is undergoing a seismic shift. For over a decade, Chimeric Antigen Receptor...
Clinical Oncology Education
In a transformative moment for thoracic oncology, new findings from the Phase III ADAURA trial have provided...
The landscape of thoracic oncology is shifting, driven by a new generation of highly selective targeted therapies....
Introduction: A Paradigm Shift in Oncology For decades, pancreatic ductal adenocarcinoma (PDAC) has stood as one of...
A transformative shift in urological diagnostics is on the horizon, following the publication of a landmark multicentre...
In a landmark development for oncology, a major UK-led clinical trial has demonstrated that tailoring treatment to...
By Sumeya Ahmed, Commissioning Editor, Future Oncology In the rapidly evolving landscape of oncology, the quest for...
The landscape of breast cancer management is undergoing a paradigm shift, moving away from "one-size-fits-all" chemotherapy protocols...
In a long-awaited breakthrough for oncology, the U.S. Food and Drug Administration (FDA) has granted approval for...
The air we breathe, once thought of as a simple necessity of life, is increasingly becoming a...
